Yixuan Gong Department of Hematology/Oncology, Tisch Cancer Institute Icahn School of Medicine at Mount Sinai Biography Publications Institution JoVE Articles Yixuan Gong has not added a biography. If you are Yixuan Gong and would like to personalize this page please email our Author Liaison for assistance. Publications A Robust Blood Gene Expression-based Prognostic Model for Castration-resistant Prostate Cancer BMC Medicine. 2015 | Pubmed ID: 26297150 The Antidiabetic Compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, Isolated from Averrhoa Carambola L., Demonstrates Significant Antitumor Potential Against Human Breast Cancer Cells Oncotarget. Sep, 2015 | Pubmed ID: 26203774 Elevated Circulating Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) Levels Are Associated with Neuroendocrine Differentiation in Castration Resistant Prostate Cancer The Prostate. May, 2015 | Pubmed ID: 25560638 Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression Cancers. 2014 | Pubmed ID: 24978435 Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer Cancer Discovery. May, 2014 | Pubmed ID: 24535670 TIMP-1 Promotes Accumulation of Cancer Associated Fibroblasts and Cancer Progression PloS One. 2013 | Pubmed ID: 24143225 The Emerging Role of Circulating Tumor Cell Detection in Genitourinary Cancer The Journal of Urology. Jul, 2012 | Pubmed ID: 22578722 EGFR Mutant Lung Cancer Current Topics in Microbiology and Immunology. 2012 | Pubmed ID: 21866438 High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells in Vitro to an Anti-IGF-1R Antibody (R1507) PloS One. 2009 | Pubmed ID: 19806209 Dual Targeting of EGFR Can Overcome a Major Drug Resistance Mutation in Mouse Models of EGFR Mutant Lung Cancer The Journal of Clinical Investigation. Oct, 2009 | Pubmed ID: 19759520 Novel MEK1 Mutation Identified by Mutational Analysis of Epidermal Growth Factor Receptor Signaling Pathway Genes in Lung Adenocarcinoma Cancer Research. Jul, 2008 | Pubmed ID: 18632602 Induction of BIM is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-dependent Lung Adenocarcinomas PLoS Medicine. Oct, 2007 | Pubmed ID: 17927446 Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase Inhibitors PloS One. 2007 | Pubmed ID: 17726540 Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor-mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2006 | Pubmed ID: 17085664 3,3'-Diindolylmethane is a Novel Mitochondrial H(+)-ATP Synthase Inhibitor That Can Induce P21(Cip1/Waf1) Expression by Induction of Oxidative Stress in Human Breast Cancer Cells Cancer Research. May, 2006 | Pubmed ID: 16651444 3,3'-diindolylmethane is a Novel Topoisomerase IIalpha Catalytic Inhibitor That Induces S-phase Retardation and Mitotic Delay in Human Hepatoma HepG2 Cells Molecular Pharmacology. Apr, 2006 | Pubmed ID: 16385077 Generazione di cancro alla prostata del paziente Derivato modelli di xenotrapianto di cellule tumorali circolanti Estrelania S. Williams1, Veronica Rodriguez-Bravo3, Uma Chippada-Venkata2, Janis De Ia Iglesia-Vicente1, Yixuan Gong2, Matthew Galsky2, William Oh2, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 3Molecular Biology Program, Memorial Sloan-Kettering Cancer Center Medicina
Generazione di cancro alla prostata del paziente Derivato modelli di xenotrapianto di cellule tumorali circolanti Estrelania S. Williams1, Veronica Rodriguez-Bravo3, Uma Chippada-Venkata2, Janis De Ia Iglesia-Vicente1, Yixuan Gong2, Matthew Galsky2, William Oh2, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 3Molecular Biology Program, Memorial Sloan-Kettering Cancer Center Medicina